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ABSTRACT
Objective:
The objective of this prospective study was to evaluate the minor salivary gland histology
of patients with a provisional diagnosis of Sjogren’s syndrome in relation to clinical
parameters to determine the level of correlation in patients with and without Sjogren’s
syndrome.
Material and methods:
A total of 71 cases with provisional diagnosis of Sjogren’s syndrome were studied who
reported between Jan 2009 till July 2009 in the Department of Oral and Maxillofacial
Pathology, Tamil Nadu Government Dental College and Hospital, Chennai, India for the
histopathological evaluation of minor salivary gland lobules.
Results:
About 25% cases having provisional Sjogren syndrome were diagnosed as definite Sjogren’s
syndrome positive. Sjogren’s syndrome affected older age group and showed characteristic
female predilection compared to non-Sjogren’s cases. Clinical features of xerostomia and
keratoconjuctivitis sicca were seen in both Sjogren’s syndrome positive and negative cases
with more expression in Sjogren’s syndrome cases. Both showed degenerative changes on
histopathological evaluation of minor salivary glands but a better correlation was found
between clinical and histological features in non Sjogren’s cases when compared to Sjogren’s
syndrome cases.
Conclusion:
Correlation was found between histological and clinical features in Sjogren’s syndrome, but it
was not consistently present in all the cases. Hence diagnosis of Sjogren’s syndrome should
be rendered carefully after observing clinical features and histological features.
Key Words:
Sjogren’s syndrome, Xerostomia, Keratoconjunctivitis sicca, Pathology, Histology, Chennai,
Tamil Nadu.
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Introduction
1INTRODUCTION
Sjogren’s syndrome (SS) is a chronic inflammatory autoimmune disorder
characterized by lymphocytic infiltration of exocrine glands and symptoms of
persistent oral and ocular dryness. The symptoms can occur alone, termed as primary
Sjogren’s syndrome, or in association with other autoimmune diseases such as
systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) referred to as
secondary Sjogren’s syndrome. It is among the three most commonly occurring
autoimmune disorders in RA and SLE and is almost equal to or behind RA in
prevalence. 1- 3 Though reported to be common disease in western countries, very few
reports has been published from our country.4-5 Prevalence of SS ranges from 0.1% to
4% due to various classifications used for the diagnosis. 1-3, 6-7 It is more prevalent in
middle aged females. Primary SS shows two age peaks, first after menarche and the
second peak after menopause. Female to male ratio ranges from 9:1 to 24:1. 8-10
No single instrumental or laboratory parameter is available for the diagnosis of
Sjogren’s syndrome. Diagnosis relies on evaluation of multiple parameters which
include subjective symptoms of dryness in eyes and oral cavity, various tests like
Resting salivary flow, Parotid flow and Schirmer’s test, Rose Bengal test, Tear
breakup time test are done for the objective signs of xerostomia and
keratoconjunctivitis respectively. Investigatory procedures like serological levels of
antibodies like rheumatoid factor, antinuclear antibodies, SS-A and SS-B and
histopathological evaluation of major and minor salivary glands for inflammation are
done to diagnose a case of Sjogren’s syndrome.11
The presence of chronic focal inflammatory infiltrates in lip salivary glands, as
assessed with minor salivary gland biopsy (MSGB), is one of the parameters included
in most criteria sets proposed for SS classification.12-16
2Currently used criteria to classify patients affected by Sjogren’s syndrome
depends on demonstration of dry eyes, dry mouth, focal collection of inflammatory
infiltrate in salivary gland biopsy and on the presence of auto antibodies in the
serum.2
This condition has been studied for over 100 yrs. 3,11 The labial salivary gland
biopsy has been considered as an important parameter among others to help confirm
the SS diagnosis for long.11 A characteristic histopathologic feature in minor salivary
glands in Sjogren’s syndrome is focal lymphocytic sialadenitis. Focal lymphocytic
infiltrates of minor salivary glands are considered target-organ specific signs of SS.17-
18 With time, the diagnostic significance of the labial salivary gland biopsy has
increased and it has been anecdotally referred to as “the gold standard” by some
physicians.19-20 The AECG criteria require either positive auto-antibodies (anti Ro/SS-
A or anti-La/SS-B) or a positive LSG biopsy to confirm SS diagnosis.
Till now, inflammatory cells foci is considered to be an important criteria,
presence of focus is characteristic but not diagnostic as it can be found in healthy
individuals, sialolithiasis, myasthenia and various connective tissue diseases and is
not always present in all cases of Sjogren’s syndrome. 21- 24
Evaluation of histopathological features in MSGB of SS can pose diagnostic difficulty
with chronic sialadenitis. MSGB is major criteria in AECG and a false diagnosis can
adversely affect the patient condition. There is less awareness among the oral
pathologist/ dentists in India about SS, though dentists can be the first person to
encounter a case of SS due to rarity in reporting of SS cases. 25-26 Literature from
India is less. Usually the histopathological picture of cases of SS is not consistent in
all the cases and exhibits various histological features and show a range of clinical
features ranging from extraglandular to systemic features.20 22
3Serological investigation of antibodies specific to SS, though is a major
criteria, is not cost effective and it is difficult to get this investigatory procedure in a
government setup where most of the patients reporting are low income group patients.
It is not always positive in all the cases of SS 21.
Thereby, we are evaluating the MSGB and trying to determine the level of
correlation present between the clinical features with which the patient is presenting
and various histological parameters seen in MSG like acinar degeneration, ductal
proliferation, ductal ectasia, vascularity, presence of inflammatory foci, germinal
center formation and diffuse inflammation, fat component, giant cells in addition to
lymphocytic foci in suspected cases of SS.
Aims and objectives
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Aim:
To evaluate the minor salivary gland histology of patients with a provisional
diagnosis of Sjogren’s syndrome in relation to clinical parameters.
Objectives:
To determine the level of correlation in patients with and without Sjogren’s
syndrome.
Review of Literature
5Greenspan JS et al 1974 27studied labial salivary gland biopsies in patients
with definite SS and control cases and reported the advantages of a focus scoring
method for evaluating severity of involvement. They concluded that focus score was a
valuable histological index for severity of salivary gland involvement in this disease
and cases with more foci had larger foci. Higher focus score also correlated with
acinar depletion but not with duration of disease. Few cases of SS with low focus
score had marked loss of acini which had been replaced by fibrosis or by fat. Both
intralobular and interlobular ducts showed varying degrees of dilatation, thickening or
thinning of the lining epithelium and oncocytic change in the epithelial cells.
However, these changes did not bear any clear relationship to the infiltrative and
destructive processes. Of the control cases, 18% showed a labial gland grade of 0,
29% a grade of 1, 42% a grade of 2 and 11% a grade of 3. Foci were seen always in
relation to duct dilation, extravasation of saliva, or extra vascular polymorphs.
Scott J. 1980 28 studied histologically non-diseased labial salivary glands from
70 necropsies evenly divided by sex and age between 18-90 years. They studied  a
limited number of morphometric features in sublabial salivary gland tissue and
showed that atrophy of acini, fibrosis, and ductal hyperplasia also occur in the minor
salivary glands with aging and affected females earlier than males. Only a quarter of
the series contained foci of lymphorecticular cells mostly in lobules affected by
parenchymal atrophy, dilatation and hyperplasia hence, they concluded that the
prevalence of lymphoplasmacytic infiltrate was unrelated to age.
Drummond JR and Chisholm DM 1984 29studied a series of 36 post-mortem
labial salivary glands from both male and female subjects with ages ranging from 25
to 80 year. Acinar atrophy, fibrous replacement, diffuse infiltrates of lymphocytes,
6ductal aberrations and oncocytic change in some were noted in the aged glands.
Ductal dilatation and hyperplasia were also common.  No simple correlation was
found between focal sialadenitis and the age and sex of the patient. Obstructive
sialadenitis characterized by acinar atrophy, duct hyperplasia, fibrous replacement and
diffuse chronic inflammatory infiltrates was observed in the labial glands and showed
an increasing severity with age.
Daniels TE, 1984 30 studied Labial salivary gland biopsies in 362 suspected
cases of Sjögren’s syndrome. He concluded that areas of labial salivary gland that
show duct ectasia, fibrosis and diffuse acinar atrophy were nonspecific degenerative
changes that were often age related and should be excluded from focus scoring.
Segerberg-Konttinen M et al, 1986 24 studied retrospectively a slide library
and found that conditions other than SS also resulted in FS more than 1. In 8/17
patients, sialolithiasis of the submandibular glands was associated with focus scores
of greater than 1, usually with little or no histological signs of obstruction and/or
infection. Focus score values of greater than 1 were found in the labial salivary glands
in 6/40 (15%) coroner's autopsies although the subjects had no clinical history or
findings suggesting SS; simultaneous specific involvement of both salivary and
lacrimal glands was however, not observed in the subjects. They suggested that a
postmortem diagnosis of SS should be made on the demonstration of focus score of
greater than 1 in both the labial salivary glands and the lacrimal glands.
The sublabial salivary glands were studied by morphometric methods by
Dewilde PCM 1986 23 in 68 healthy volunteers to establish possible changes related
to age in those tissue components that are affected in Sjogren's syndrome and
connective tissue diseases (which might simulate Sjogren's syndrome). There was an
7increase in the amount of connective tissue and intralobular ducts with age and a
corresponding decrease in acinar tissue. The amount of diffuse lymphoplasmacytic
infiltrate and the vascularity of the tissue remained constant with age. In 22% of
subjects lymphocytic foci were seen, 40% of these had a score >1 focus suggestive of
Sjogren's syndrome. The aging process was accompanied by atrophy of acini and
increase in fibrosis. Intralobular ductal hyperplasia was also observed with aging.
Jacobsson LT et al 1989 31, studied 705 randomly selected subjects, aged 52-
72 years who answered a simple questionnaire, and of whom 247 (35%) reported
symptoms of dry eyes or dry mouth.
Segerberg-Konttinen M et al 1989 32 , conducted a postmortem study 102
consecutive medico legal post-mortem subjects to identify signs of focal adenitis in
labial, submandibular, and lacrimal glands. There were 19 subjects (18.6%) with
focus scores exceeding 1 in one or two types of the glands. Among the 19, five had a
disease which is generally associated with Sjögren's syndrome or is autoimmune in
nature. He found that fibrosis, atrophy, and fatty change occurred most often in the
labial salivary glands in those over 50 years of age with or without high focus scores.
Shah F et al 199233, investigated the association between labial salivary gland
histopathological changes and the clinical and serologic features of 192 patients with
suspected connective tissue disorders. There were significant associations between
positive findings on lip biopsy and the presence of keratoconjunctivitis sicca and
positive Ro antibodies. In patients with LSG focus scores > 1, approx 50% had
parotid gland enlargement. Significant associations were found between LSG focus
scores > 1 and KCS. There was no significant association between an LSG focus
score of 1 and sicca, KCS or glandular enlargement. The sensitivity of the Ro
8response for the presence of sialadenitis was low (0.485) but the specificity was high
(0.967). Whereas, sicca symptoms were neither predictive (0.459), nor specific
(0.379) but extremely sensitive (0.746) for focal sialadenitis. Salivary or lacrimal
gland enlargement was likewise not predictive (0.558) or sensitive (0.492) for focal
sialadenitis. A positive ANA result was associated with a focus score of 1 (P=0.018).
Anti-Ro antibody was strongly associated (P=0.0001) and was very specific (0.960)
for a focus score of 1.
Speight PM et al, 1992 34studied unstimulated salivary flow in different age
groups and found that 70% of patients with Sjogren’s syndrome had decreased flow.
They found that unstimulated flow of 0-1 ml.min or less is highly specific for
Sjogren’s syndrome. They also found that salivary flow was higher in patients with
rheumatoid disease and secondary SS as compared to primary SS. However, they
found no significant correlation between unstimulated flow rate and focus score.
Coll J et al in 1992 35investigated 142 patients (62 with definite Sjogren’s
syndrome, 24 with probable Sjogren’s syndrome, and 56 control cases). Definite
keratoconjunctivitis sicca was present in 34 patients (24%) and xerostomia in 56
(39%) whereas both were present in 28 patients (20%). They however, also found
10% of the control subjects with a positive Schirmer's test.
Daniels TE, et al in 1994 36 studied LSG biopsy specimens from 618 patients
with suspected SS to determine the association between patterns of inflammation in
labial salivary glands (LSG) and the ocular component of Sjogren’s Syndrome(SS).
They found a stronger KCS association in patients whose LSG biopsies showed focal
inflammation and chronic sialadenitis to be a  common feature of labial salivary
glands which is neither associated with SS nor an end stage of SS.
9Vitali C et al 1994 12, tested sensitivity and specificity of tests for ocular and
oral involvement in Sjogren’s syndrome. Data from 22 centers and 11 countries was
collected on a total of 447 patients with SS (246 with primary SS and 201 with
secondary SS) and 246 controls (of whom 113 had a connective tissue disease without
SS). Among the ocular tests, Schirmer’s test showed the best balance between
sensitivity and specificity (76.9% and 72.4%). The oral tests (except USWC) were
generally more reliable than the ocular tests in diagnosing SS. USWC had a
sensitivity and a specificity of 56.1% and 80.7%, respectively, with >1.5 ml of saliva
collected in 15 minutes being considered the normal limit. Abnormal results for all of
the ocular and oral were less frequent and less marked in patients with secondary SS.
MSGB (where the presence of at least one inflammatory focus was considered as
indicative for the diagnosis) showed a good balance between sensitivity and
specificity (82.4% and 86.2%, respectively). The agreement between USWC and
MSGB was somewhat lower; if one considered as diagnostic score of ≥1.The
presence of inflammatory foci in lip biopsies of patients without SS did not appear to
be significantly correlated with age. They showed that both acinar fibrosis and ductal
abnormalities were linked to progressive, age-related involution of the minor salivary
glands, and that they were observed in equal numbers of patients with and without SS.
The number of foci found in patients with primary SS was significantly higher than
that observed in patients with SS associated with other CTD. The quantity of
inflammatory infiltrates was considerably reduced in the patients with secondary SS
associated with RA or with Systemic sclerosis. 25% of those patients with a CTD but
not SS had a focus score ≥1. Their study indicated that no single test of oral or ocular
involvement was sufficiently sensitive and specific to form the basis for a diagnosis of
SS.
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Vitali C et al, 1996 37undertook a study to assess the European classification
criteria for Sjogren’s syndrome in a series of clinically defined case. They tested a
total of 278 cases (157 SS patients and 121 non-SS controls) collected from 16 centers
in 10 countries and found that minor salivary gland biopsy was the most accurate for
the diagnosis of SS (89.0 and 84.1 when focus scores - 1 and >1, respectively, were
considered as indicative of the diagnosis), followed by parotid sialography (83.3%),
and Schirmer's test (77 .0%).
Field EA and coworkers 1997, 38 studied 100 consecutive patients which
reported a daily feeling of oral dryness for at least 6 months. On sialometry 39
patients had a low unstimulated flow rate (≤0.1 ml/min) with only 17 patients with
complete lack of unstimulated saliva. They suggested that salivary hypofunction and
resultant xerostomia were not inevitable consequences of ageing as reductions in
salivary flow do not necessarily correlate with diminished oral health. Their study
yielded that a complaint of dry mouth does not always result in a diagnosis of SGH,
as only 39% of the patients attending the xerostomia clinic were found to have
objective evidence of reduced salivary flow and only 40% of patients were diagnosed
as SS. However, some individuals with a very low flow rate did not complain of oral
dryness and others with copious amounts of saliva felt that they have a dry mouth
Hay EM in 1998 39 conducted a cross sectional population based survey on
341 subjects to determine associations between symptoms of dry eyes and dry mouth
and objective evidence of lacrimal and salivary gland dysfunction in a population
based sample. They interviewed for the presence of dry eyes and mouth and examined
for Schirmer’s test and unstimulated salivary flow rate. They found 24% had dry eye
symptoms, 29% dry mouth symptoms, and 14% both. There was only a weak
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association between the presence of oral or ocular symptoms and their respective test
results. Associations were strongest between dry mouth symptoms and positive test
results and in subjects under 55 year (younger) of age.
Skoupouli FN et al in 2000, studied the impact of primary Sjogren’s
syndrome (pSS) on overall survival in a prospective study of a cohort of 261 patients
with pSS. He found that low C4 levels and mixed monoclonal cryoglobulinemia were
linked with an approximately 6- to 8-fold relative risk for the development of
lymphoma.
Ohara T et al 2000 40, evaluated the diagnostic value of laboratory parameters
in relation to histopathological findings in Sjogren's syndrome (SS) in 96 patients.
The percentage of cases with positive assays of rheumatoid factor and anti-SS-A/Ro
antibodies was significantly higher in definite SS. 80% of patients with definite SS
had specific abnormal findings on histology in salivary glands. However, 20% of
patients did not have such findings and were diagnosed as definite SS from specific
abnormal findings in sialogram. No useful laboratory parameters were found for the
diagnosis of secondary SS. Schirmer’s test had a sensitivity of 64% and specificity of
85% in the diagnosis of primary SS. However, no significant correlation for
Schirmer's test was observed between the negative SS group and the definite SS
group.
Kalk WW et al 2001 assessed the value of glandular sialometry and
sialochemistry as diagnostic instruments in SS in a group of 100 consecutive patients
referred for diagnosis of SS. Patients were classified as positive or negative for SS
according to the revised European classification criteria. Patients with SS differed
clearly from those who tested negative for SS, showing lower
12
submandibular/sublingual (SM/SL) flow rates. Their study resulted that all glandular
secretary flow rates were inversely related to duration of oral  symptoms in SS group,
however, when the disease was still incipient, sialometry might not show any loss of
glandular function.
Al-Hashimi I et al in 2001 41, examined 38 minor salivary gland biopsies to
study the reproducibility of biopsy in Sjogren’s syndrome. They examined biopsies at
6 mm, 50 mm, 100 mm, 150 mm, 200 mm, and 250 mm tissue depths and found wide
range of grade variability at all depths. Their study yielded that no tissue depth was
consistently reproducible for any grade.
Dawson LJ et al 200142, aimed to determine if the salivary gland
hypofunction associated with primary Sjogren’s syndrome (SS‐1) is more severe
than that associated with secondary Sjogren’s syndrome (SS‐2).  They
retrospectively compared for age and gender matched, patients diagnosed with SS-1
or SS-2 according to the preliminary European criteria. They found no significant
differences of unstimulated whole salivary flow rates between individuals with SS-1
or SS-2 and hence concluded that the severity of salivary gland hypofunction does not
appear to be related to the clinical variant of Sjogren’s syndrome.
Price EJ and Venables PJ 2002 43 collected clinical, serological and
histological data on 34 patients presenting with dry eyes and/or mouth who did not
satisfy the Vitali criteria for the diagnosis of SS and compared with 136 patients with
primary SS, 38 patients with secondary SS, and 13 patients without SS.
Questionnaires on symptoms from each group were compared with 43 healthy
controls. They found no evidence that age, salivary gland atrophy or subclinical SS
accounted for the symptoms in dry eyes and mouth syndrome.
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Rosas J et al, 2002, 44studied usefulness of basal and pilocarpine-stimulated
salivary flow in primary Sjogren’s syndrome and their correlation with clinical,
immunological and histological features. They investigated the clinical and
immunological characteristics of 60 consecutive patients with primary SS which
fulfilled four or more of the preliminary diagnostic European criteria for SS.
Unstimulated (basal) salivary flow (BSF) was measured in all patients. The mean BSF
for SS patients was 1.40±0.17 ml with 83% patients showing a BSF < 1.5 ml.
Radfar L et al, 2002 45, studied prevalence and clinical significance of
lymphocytic foci in minor salivary glands of 54 healthy volunteers and found 15%
with focal lymphocytic infiltrate. None of these individuals had subjective xerostomia
or dry eyes. The positive FS ranged from 2 to 6. FS did not correlate with age,
smoking, serologic findings, or salivary flow in these patients. They concluded that
lymphocytic infiltration in minor salivary glands was not uncommon among
individuals without a history of salivary gland dysfunction
Misra R et al 2003 26, studied 26 patients (21 being women) with dry eyes,
dry mouth, and arthritis/arthralgia. Minor salivary gland biopsy provided a definitive
diagnosis in 16/26 (60%). The important laboratory abnormalities being
hypergammaglobulinaemia (16/20),antinuclear antibodies (18/26), anti-La (11/19)
and anti-Ro (10/19).  They found that prevalence of primary Sjogren's syndrome was
rare even in tertiary care rheumatology clinics in India and the clinical and
immunological profile were also similar to that reported in Western countries.
Salomonsson S et al 2003 46, underwent a study to find out cellular basis of
ectopic germinal center (GC) formation and autoantibody production in the target
organ of patients with Sjogren’s Syndrome. 165 minor salivary gland biopsy samples
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from patients of SS were screened for GC-like structures and GC-like structures were
observed in 17% of patients. There was no statistically significant difference between
occurrence of these structures in patients with primary SS and in those with secondary
SS. The GCs formed within the target tissue showed functional features with
production of autoantibodies (anti-Ro/SSA and anti-La/SSB) and apoptotic events (by
TUNEL staining), and there was increased local production of anti-Ro/SSA and anti-
La/SSB autoantibodies  (P = 0.04) in patients with GC development.
Kikuchi M et al 2004 47, examined histologically labial, sublingual and
submandibular salivary glands from 53 autopsy subjects without any symptoms with
an average age of 84 years. They concluded that there was no relationship between
degree of lymphocytic infiltration in minor salivary gland and age.
Sánchez-Guerrero J et al 2005 48 investigated randomly chosen 300 patients
from rheumatology and internal medicine clinics to find prevalence of SS. The mean
age of the subjects was 42.8±15.7 year. The minimum prevalence of SS in the
population studied was found to be 13.3% (95% CI, 9.5–17.1%), primary SS
(prevalence 2.7%) and secondary SS (prevalence 10.7%)
Morbini P et al 2005 49 evaluated a cumulative focus score (cFS) on three
slides cut at 200-μm intervals from each of a series of 120 salivary biopsies. The
diagnostic performance of AECG classification was significantly improved when the
cFS was entered in the AECG classification; the improvement was mostly due to
increased specificity in biopsies with a baseline FS ≥ 1 but <2.
Jonsson MV et al 2005 50 found that lymphoid organization in the shape of
ectopic germinal centers were detected in 33 of 130 consecutive minor salivary gland
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biopsies of the chronic, autoimmune disorder Sjögren's syndrome and coincided with
increased focus score.
Delaleu N et al 2005 51, said in there paper that despite chronic symptoms of
severe oral dryness manifested by a 80-90% decrease in salivary flow compared with
normal individuals, the acinar and ductal structures appeared not to be destroyed to
such extent and   in addition to lymphocytic infiltration, acinar epithelial atrophy, and
progressing fibrosis can be observed with glands of patients with SS.
García-Carrasco M et al 200652 studied patho-physiology of Sjogren’s
syndrome. They concluded that degree of glandular destruction and symptoms of
dryness do not seem to be directly related to the number of infiltrating lymphocytes.
Venables PJ. 2006 53 in their study found that sicca symptoms were not fully
associated with inflammation as low dose steroid which are capable of reducing
inflammation did not improve salivary flow. Salivary gland swelling occurs in about
60% of patients with Sjogren’s syndrome, and may affect any of the major or minor
salivary glands.
Pijpe J et al, 2007 54, compared Parotid gland biopsy with labial biopsy in the
diagnosis of patients with primary Sjogren's syndrome. A total of 30 labial and
parotid biopsies were studied. It was found that the presence of foci, confluence of the
infiltrate and fibrosis was comparable in both major and minor salivary glands.
Germinal centers were present in four patients, in both labial and parotid biopsies.
Lymphoepithelial islands (LEL) were present only in parotid gland tissue, while labial
salivary gland tissue showed more atrophy and therefore, in addition to the focus
score, benign LELs in the parotid gland can be used as an additional aid in diagnosis.
They concluded that a parotid biopsy has a diagnostic potential comparable with that
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of a labial biopsy in the diagnosis of pSS, and may be associated with less morbidity
in contrast to labial salivary glands.
Jonsson MV et al 2008 55, retrospectively studied minor salivary gland
biopsies with focal lymphoid aggregates corresponding to focus score > 1 fulfilling
the American-European criteria for pSS and evaluated for the presence of GC-like
morphology. GC-like features were observed in 28% biopsies. Mean inflammatory
focus score and frequency of patients with unstimulated salivary secretion
≤1.5ml/15min was significantly higher in GC-positive compared to GC-negative
samples. Enlarged salivary glands were observed in 28% patients, without any linkage
to presence or absence of GC-like features.
Jonsson MV and Skarstein 200855, studied that presence of Follicular
dendritic cells confirm lymphoid organization in the minor salivary glands of primary
Sjogren’s syndrome. A randomly selected cohort of 60 patients who fulfilled the
revised American–European criteria for primary SS was investigated in this study.
Biopsies with primary SS were investigated for the expression of CD21, CD23, CD35
and IgD by immunohistochemistry. 20% of the biopsies in this random sample had
GC-like morphology in the routine H&E tissue section The mean focus score was
significantly higher in the GC+ patients (P < 0.05).
Mathews SA et al, 2008 10studied Oral Manifestations of Sjogren’s
Syndrome. They found acinar epithelial atrophy and progressing fibrosis within
glands of persons with Sjogren’s syndrome and in spite of chronic symptoms of
serious oral dryness, as seen by 80-90% decrease in salivary flow compared with that
in normal individuals, the acinar and ductal structures do not appear to be destroyed to
such an extent.
17
Caporali R et al 2008 56, underwent a study to investigate safety and
usefulness of minor salivary gland biopsy by analyzing  retrospectively 452 patients
with suspected SS. 93 patients (24.5%) had  focal sialadenitis upon histopathologic
evaluation; of these, 87 (94.5%) satisfied the AECG criteria set. Only 1.6% of patients
who did not have the requisites for the diagnosis of SS had a chronic focal
sialadenitis. They concluded that MSGB is a simple, safe, and reliable tool for the
diagnosis of SS and amyloidosis, and therefore is suitable for more extensive
application
Bamba R et al 2009 57, retrospectively studied salivary gland biopsies of 46
patients of SS, 39% of these patients had a negative biopsy (grade <3) and 61% had a
positive biopsy (grade = 3 or 4). Their study resulted that salivary gland swelling, and
abnormal serology (anti-Sjogren syndrome A/anti- Sjogren syndrome B) were more
prevalent in the positive lip biopsy group (grade 3 or 4). Out of the 12 patients who
had sicca symptoms and positive serology, nine (75%) had grade 4. Presence of sicca
symptoms and positive serology were predictive of a positive biopsy (p < .017).In
their study, clinical presentation of sicca symptoms and positive serology reliably
predicted the results of a lip biopsy.
Eliasson L et al 2009 58, studied 142 individuals, aged 18–82 years. Feelings
of oral dryness were assessed and resting whole saliva flow rates were measured by
conventional methods. The resting secretion rates were significantly lower in subjects
with complaints compared with individuals of no complaints. Also, some individuals
with normal secretion rate reported dry mouth feelings. It was suggested that local
areas of dry mucosa, with lowered flow of saliva and of mucous production, could
trigger a sensation of dry mouth.
Material and Methods
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MATERIALS & METHOD
Eighty four consecutive patients who attended the OPD at Tamil Nadu
Government Dental College & Hospital, Chennai from a period of Jan 2009 to July
2009 (including both months) were included in this study. The patients were referred
under suspicion of SS by rheumatologists, neurologists and medicine physicians.
Reasons for referral were not limited to polyarthralgia and connective tissue diseases
but also included ocular or oral manifestations such as eye dryness, mouth dryness,
swelling of the salivary glands and systemic problems such as neurological disorders.
Out of 84 cases 14 cases were excluded due to insufficient data due to various
reasons. So, 71 cases were included in the study. The cases were divided into two
groups as SS+ve and SS-ve group depending on the diagnosis which was rendered
according to the American-European Consensus Group Classification criteria for
Sjogren’s syndrome (2002).59
Clinical Parameters
General patient history regarding age, chief complaints, duration and
specifically oral and ocular symptoms were recorded on a performa in a questionnaire
format according to the revised American-European criteria 2002.
ASSESSMENT OF THE ORAL COMPONENT
The three questions assessed oral dryness.
Oral symptoms
1. Have you had a daily feeling of dry mouth for more than 3 months?
2. Have you had recurrently or persistently swollen salivary gland as an adult?
3. Do you frequently drink liquid to aid in swallowing dry foods?
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Positive response to any of the three confirmed the presence of oral dryness symptom.
Method to collect Unstimulated whole saliva (Sialometry)
Unstimulated whole saliva flow (USWF) was measured by the spitting
method. The patients were instructed not to eat, drink, or smoke during 90 minutes
preceding the sialometric assessment. The patient was seated comfortably, he or she
was instructed to rest for 5 min before the test, minimize orofacial movements and not
to speak. Before starting the procedure, but not later, the patient swallowed any
residual saliva and was then asked to allow all saliva to accumulate on the floor of the
mouth and to spit it gently into a graduated test tube every minute. Saliva was
collected for a period of 15 min 34 and the measured volume expressed in ml/15min.
The cutoff value on this study was 1.5 ml/15 minutes for the reason that 1.5 ml/15
minutes had been selected as the cutoff value in the American-European Consensus
Group Classification criteria for Sjogren’s syndrome (2002).59
Unstimulated whole salivary flow less than or equal to 1.5ml/15min was considered
as positive objective sign for dry mouth.
CLINICAL PARAMETERS
ASSESSMENT OF THE OCULAR COMPONENT
The three questions assessed ocular dryness.
Ocular symptoms:
1. Have you had daily, persistent, troublesome dry eyes for more than 3 months?
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2. Do you have recurrent sensation of sand or gravel in the eyes?
3. Do you use a tear substitute more than 3 times a day?
Positive response to any of the three confirmed the presence of ocular dryness
symptom.
The Schirmer test
The Schirmer test was carried out in the Government Eye Hospital Egmore,
Chennai.
Procedure:
The Schirmer test was carried with a filter-paper strip (Schirmer tear test
standardized sterile strips) of 0.5 to 30 mm. The strip was placed in the lower fornix
between the medial and lateral third of the eyelid of the unanaesthetized eye. After 5
minutes, the amount of wetting was measured from the extraforniceal position of the
strip.59
A value of 5 mm or less per 5 minutes was considered as a positive objective criteria
for keratoconjunctivitis sicca (KCS).59
Patient’s medical history especially the presence or absence of connective tissue
disease was obtained from the medical records by Department of Rheumatology,
Madras Medical College & Government General Hospital, Chennai.
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Labial salivary gland biopsy
Labial salivary gland biopsy (LSGB) was performed in the Department of
Oral Surgery, Tamil Nadu Government Dental College & Hospital, Chennai as a part
of routine diagnostic procedure. Local anesthesia (2 % lidocaine) was injected deep to
the glandular tissues of the lower lip. A 1.5 to 2.0 cm linear incision was made in the
mucosa, parallel to the vermillion border and lateral to the midline. Following blunt
dissection, the margins of the salivary glands were removed individually and placed
in fixative. No surface mucosa was removed and the mucosal incision was reapposed
with 4-0 braided silk or plain gut sutures. Sutures were removed after 5 to 7 days.60
Then the specimen was sent for processing and routine H & E staining in Department
of Oral Pathology for histopathological evaluation.
MSBG samples were fixed in formalin, processed, and embedded in paraffin
according to standardized laboratory methods.
Using the Leica microtome, 4 micron meter thick sections were cut from the
blocks for Ehrlich Hematoxylin and Eosin staining.
Procedure for Hematoxylin and Eosin staining61
 Sections are deparaffinised with xylene.
 Hydration with descending grades of alcohol.
 The sections are drained and transferred to hematoxylin, where they are left
for 10 minutes.
 The slides are then drained and washed in running water until the sections are
blue.
 The sections are dipped in acid alcohol where they are agitated for a few
seconds and again washed in running water until blue again.
 The sections are counterstained with eosin for 30 seconds.
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 The sections are washed in running water for 3-4 minutes, to differentiate the
eosin.
 After draining, the sections are dehydrated in ascending grades of alcohol.
 The sections are cleared with xylol, where they are given two changes for 30
seconds each.
 The sections being clear, the slides are dried and mounted with Distrene 80
Dibutyl Phthalate Xylol (DPX) under a coverslip.
Results
1. Nuclei: Blue
2. Cytoplasm: Varying shades of pink
3. Collagen: Pink
The stained and mounted slides for all cases were examined under the light
microscope and following histological parameters were evaluated.
HISTOLOGICAL PARAMETERS
 Apparently normal
 Acinar Degeneration
 Ductal ectasia/ dilatation
 Ductal proliferation
 Squamous metaplasia
 Epimyoepithelial islands
 Inflammatory infiltrate
o Focal
o Diffuse
 Germinal centre formation
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 Interstitial fibrosis
 Multinucleated giant cells
 Vascular component
 Adipose tissue component
Histological features
Acinar Degeneration
The secretory part of the gland consisting of serous and mucous acini was
observed for the presence or absence of degeneration. Total loss or degeneration of
acini to duct like structures was considered as degeneration present. The criteria of
presence of degeneration were set arbitrarily.
Fibrous tissue
Increase in the connective tissue within the sublabial salivary gland or in the
lobules of the salivary gland tissue was considered as present. The fibrous capsule
was excluded.
Ductal proliferation
Increase in the number of duct in a given area within the glandular lobules was
considered positive. The criteria were set arbitrarily. Larger ducts in the connective
tissue, septa, and hilum of a gland were not included.
Ductal ectasia
Increase in the diameter of the intralobular duct was observed and compared
relatively to the normally present ducts and increase in the diameter was given as
presence of ectasia.
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Vascularity
All vessels situated within the lobules were counted in high power fields in all
the lobules. Total count of the vessels was divided by the total number of high power
fields. The vessels were divided into three groups according to the number of vessels
per high power field. The count of vessels per HPF between 0-2 was given as mild, 2-
5 as moderate and above 5 as high. The larger vessels in the fibrous septa and hilum
were excluded.
Lymphocytic focus
An aggregate of more than 50 lymphocytes and histiocytes, usually with a few
peripheral plasma cells constituted a lymphocytic focus. A lymphocytic focus has a
great density of inflammatory cells and is usually very well demarcated. The
mononuclear infiltrate was classified as focal, when periductal and/or perivascular,
and diffuse, when sparsely interspersed with seromucinous cells. These aspects were
classified as present or absent. Labial salivary gland biopsies were assessed
histologically using criteria initially described by Chisholm and Mason.  They defined
a focus as an aggregate of at least 50 lymphocytes, and found that more than one
focus/4 mm2 area of gland was seen only in patients with SS.62
Germinal center formation
GC-like features were observed as well-circumscribed chronic inflammatory
cell infiltrate consisting of at least 50 mononuclear cells, presenting with a densely
packed dark zone and a light zone, within otherwise normal salivary gland epithelium.
Scattered inflammation
These consisted of the plasma cells and lymphocytes in the fibrous stroma of
the gland and areas of fibrosis. A diffuse infiltrate has a low density of cells, mostly
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plasma cells. All other phenomena of inflammatory activity that did not satisfy the
definition of a lymphocytic focus were included in the definition of
lymphoplasmacytic infiltrate.
Grade scores ranged from 0 to 4 for focal inflammation.
0=absent infiltrate
1=slight infiltrate
2=moderate infiltrate
3=1 focus of at least 50 lymphocytes/4 mm2 of gland.
4≥1 foci of at least 50 lymphocytes/ 4 mm2 of gland.
The histological parameter was considered as negative in the absence of any
inflammatory infiltrate (FS = 0) and in the presence of less than 1 focus per 4 mm2 (0
< FS < 1) 59; the presence of one or more foci per 4 mm2 was considered positive.
Less-than-optimal tissue area (biopsy section area less than 4 mm2) was not
considered a criterion for exclusion, provided that at least one normotrophic glandular
lobule had been sampled.
American-European Consensus Group Classification criteria for Sjogren’s
syndrome (2002) 59
I. Ocular  symptoms: a positive response to at least one of the following questions:
Have you had daily, persistent, troublesome dry eyes for more than 3 months?
Do you have a recurrent sensation of sand or gravel in the eyes?
Do you use tear substitutes more than 3 times a day?
II. Oral symptoms: a positive response to at least one of the following questions:
Have you had a daily feeling of dry mouth for more than 3 months?
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Have you had recurrently or persistently swollen salivary glands as an adult?
Do you frequently drink liquids to aid in swallowing dry food?
III. Ocular signs: objective evidence of ocular involvement defined as a positive result
for at least one of the following two tests:
Schirmer’s test, performed without anesthesia (<5 mm in 5 minutes)
Rose bengal score or other ocular dye score (>4 according to van Bijsterveld’s
scoring system)
IV. Histopathology: In minor salivary glands  focal lymphocytic sialoadenitis,
evaluated by an expert histopathologist, with a focus score >1, defined as a number
of lymphocytic foci per 4 mm2 of glandular tissue
V. Salivary gland involvement: objective  evidence of salivary gland  involvement
defined  by a positive result for at least one of the following diagnostic tests:
Unstimulated whole salivary flow (<1.5 ml in 15  minutes)
Parotid Sialography showing  the presence of diffuse sialectasias  without
evidence of obstruction  in the major ducts
Salivary scintigraphy showing  delayed uptake, reduced concentration and/or
delayed excretion  of tracer
VI. Autoantibodies: presence in the serum of the following autoantibodies:
Antibodies  to Ro(SSA) or La(SSB) antigens, or both
For primary  SS
In patients  without any potentially  associated disease, primary  SS may be
defined  as follows:
27
The presence of any 4 of the 6 items is indicative  of primary  SS, as long as
either item IV   (Histopathology) or VI (Serology) is positive
The presence of any 3 of the 4 objective  criteria items (that is, items III, IV,
V, VI)
For secondary SS
In patients  with a potentially  associated disease (for instance, another  well
defined  connective tissue disease), the presence of item I or item II plus any 2
from among items III, IV, and  V may be considered as indicative  of
secondary SS
Exclusion criteria:
Past  head and  neck radiation treatment
Hepatitis  C infection
Acquired  immunodeficiency disease (AIDS), Pre-existing lymphoma
Sarcoidosis
Graft  versus host disease
Use  of anticholinergic drugs (since a time shorter than 4-fold the half life of
the drug)
Observations &Results
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A Total 71 cases were studied and 18(25.4%) cases were found SS positive.
Remaining 53(74.6%) cases were diagnosed SS –ve.
Figure 1
Out of 18 SS positive cases, 3(16.7%) were having primary SS and remaining
15(83.3%) had secondary SS.
Figure 2
Gender distribution in provisional SS cases is illustrated in table 1 (below). All SS
positive cases were females and no male was diagnosed SS positive.
Total number of SS+ve cases
Primary SS +ve cases
25%
75%
Total number of SS-ve cases
17%
83%
Scondary SS +ve cases
29
Male Female
SS +ve 0 18
SS –ve 5 48
Total 5 66
Table 1
Figure 3
Gender distribution in SS positive cases
Figure 4
Total number of SS+ve cases(Male)
Total number of SS+ve cases(Female)
7%
93%
Total number of cases(Male)
Total number of cases(Female)
0%
100%
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Table below list the distribution of total cases diagnosed in various age groups.
No of cases
SS -ve cases SS +ve cases Total
A
ge
 
gr
o
u
p
0-10 0 0 0
11-20 0 0 0
21-30 13 2 15
31-40 11 4 15
41-50 20 5 25
51-60 8 5 13
61-70 1 2 3
Total 53 18 71
Table 2
Of total 71 cases, Xerostomia was positive in 54 cases and negative in 17. Of 54
Xerostomia positive cases, 18 were found SS positive. There was no case of SS
without Xerostomia. Table 2(below) summarizes the occurrence of Xerostomia and
USWF in total number of cases.
Xerostomia
(occurrence in all cases)
+ve -ve
U
S W F
+ve 27 0
-ve 27 17
Table 3
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Table 4(below) summarizes the occurrence of Xerostomia and USWF in SS positive
cases and SS negative cases.
Xerostomia occurrences
SS +ve cases SS –ve cases
+ve -ve +ve -ve
U
SW F +ve 18 0 9 0
-ve 0 0 27 17
Table 4
Figure 5
Figure 6
Xerostomia +ve in total cases
U
SW F
100%
0%
Xerostomia +ve in SS +ve cases
Xerostomia -ve in SS +ve cases
76%
24%
Xerostomia -ve in total cases
U
SW F
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A closer look at Xerostomia and USWF occurrences inferred that presence of
Xerostomia and USWF together increases the probability of SS occurrence.
As illustrated in figure 4 below, 33.3% of Xerostomia positive cases, 54.8% of KCS
positive cases , 66.7% of USWF positive cases and 83.3% of ScT-1 positive cases
were found SS positive cases. So it can be inferred that there is close correlation
between positive ScT-1 test and occurrence of SS.
Figure 7
Figure 5 below shows the occurrence of positive KCS in total cases and SS positive
and SS-ve cases respectively.
Figure 8
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Figure 9
Histopathological results
Of total 71 cases, 34/71 (47.9%) showed acinar degeneration and 37/71 (43.7%) were
free from acinar degeneration. In 10 cases of SS, AD was present whereas it was
present in 24 SS-ve cases. AD was not found in 8 SS +ve cases and 29 SS –ve cases.
ACINAR DEGERATION IN ALL CASES
AD
Present Absent
SS
Present 10 8
Absent 24 29
Total cases 34 37
Table 5
KCS +ve in SS+ve cases
SS
94%
6%
KCS -ve in SS+ve cases
SS
34
Figure 10
DISTRIBUTION OF DUCTAL PROLIFERATION, DUCTAL ECTASIA AND
FOCAL INFLAMMATION
DP DE FI
Present Absent Present Absent Present Absent
SS
Present 8 10 1 17 10 8
Absent 27 26 4 49 8 45
Total cases 35 36 5 66 18 53Figure 11 Figure 12 Figure 13
Table 6
Figure 11
52%
51%
SS
48% AD +ve in totalcases
AD -ve in total
cases
49% DP +ve in totalcases
DP -ve in total
cases
SS
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Figure 12
Figure 13
Scattered Inflammation, Interstitial Fibrosis and Adipose Tissue
SI IF AT
Present Absent Present Absent Present Absent
SS
Present 13 5 7 11 5 13
Absent 23 30 19 34 12 41
Total cases 36 35 26 45 17 54
Table 7
75%
SS
7%
93%
DE +ve in total
cases
DE -ve in total
cases
25% FI +ve in total
cases
FI -ve in total
cases
SS
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Figure 14
Figure 15
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cases
IF -ve in total
cases
37
Figure 16
Figure below is snapshot of observed histopathological occurrences in total
cases
Figure 17
Distribution of Vascularity observed in the both the groups are plotted in figure 18
(below)
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Figure 18
Vascularity distribution in total 71 cases is tabulated in table below and ploted in
figure 20 (below)
0-2 2-5 >5
Total cases 18 41 12
Total cases (%) 25.4 57.7 16.9
Table 8
Figure 19
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Distribution of Acinar degenrationin relation to age.
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Discussion
From 1 Jan 2009 to 30 Jul 2009, 84 cases with the provisional diagnosis of SS
presented to the department of Oral Pathology, out of which only 71 cases were taken
into consideration due to lack of data for rest of the cases.
18 cases were diagnosed as SS which constituted 25.4% of the total cases under study.
Of these, 3 cases were of primary SS and 15 cases were of secondary SS. Primary SS
cases occupied 16.7% of the SS cases and 4.2% of total study cases. Secondary SS
cases were more than Primary SS syndrome and were around 83.3% of SS cases and
21.1% of total cases. The ratio of occurrence of primary SS to secondary SS was 1:5.
GENDER DISTRIBUTION
Female constituted 93% of sample size and males 7%. So, the ratio of female
to male in total sample of provisional SS cases was 13.2:1.
In SS positive cases all the 18 patients were female and none of the male patients was
found SS positive. The ratio of female to male in SS positive cases ranged from 9:1 to
as high as 24:1. 8-10As no male was affected so our male to female ratio comes out to
be more than the highest reported ratio. But our sample size was small and serological
factor was not taken into consideration so there are chances that with all the required
investigations we could have got a more predictive data and preponderance of the
gender in this study.
48 female patients (90.6%) and 5 male (9.4%) comprised the SS negative group. So
the female to male ratio was 9.6:1 which is significantly lower than the proportion of
female patients affected in relation to male in SS+ve group in the present study, but is
similar to the usual ratio of female to male patients affected with SS. 8-10
AGE
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The age of the patients reported ranged from 3rd decade till 7th decade with a
mean of 42.3±11 yrs.
Mean age of females was 42.2 yrs. Mean age of male was 43.4 yrs.
No case in the 1st and 2nd decade reported with the complaint. This is in accordance to
the usual age group which is affected by connective tissue disease mainly rheumatoid
arthritis. Though Sjogren’s syndrome can affect any age but most commonly occurs
in  4th and 5th decade of life. So the present study group matches with the literature.1
The age of the patients affected with SS ranged from 3rd to 7th decade with mean age
of  45.4±11.4 yrs.
Mean age of secondary SS cases was 46.1 yrs and of primary SS cases was 42 yrs.
SS negative cases also spanned from 3rd decade till 7th decade with mean age of
42.9±10.8 yrs.
Mean age of males was 43.4 yrs and that of females was 41.1 yrs in SS-ve cases.
Mean age of SS positive cases was higher than SS negative cases and total cases. This
is in accordance with the literature which states that the patients which are affected
with the syndrome are generally older than the patients of connective tissue disease.
As this is a slowly progressing condition and diagnostic delay is present due to wide
spread spectrum of systemic manifestation, is usually diagnosed later than the other
diseases. Also patients suffering from primary SS are usually younger than the
secondary SS cases, though in the present study the number of primary SS cases are
very less to give a more significant age predilection but still it can be inferred that it
tends to occur in slightly younger patients than those who manifest connective tissue
along with it. Mean age of SS negative cases was slightly higher though not
significant than the mean age of total sample. The cases of SS+ve were older than the
case of SS-ve as it is an insidious condition and will show its sign and symptom
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slightly late in life and thus the present age group predilection is in accordance with
the literature.
There was no case below 2nd decade with the complaints.  25/71(35.2%) cases among
all belonged to 5th decade. 15(21.1%) cases were in 3rd and 4th decade. The number
slightly decreased in 6th decade to 13(18.3%) and only 3(4%) cases were of 7th
decade.
Cases of SS showed a gradual increase in frequency with the age which lowers down
in the oldest group [2/18(11.1%) in 4th, 4/18(22.2%) in 5th, 5/18(27.8%) in 6th and
2/18(11.1%) in 7th decade]. So most of the patients were affected in middle and old
age group that is 4th to 6th decade, which is in accordance with other studies which
showed middle aged women to be most affected with SS.
In SS-ve group 13/53(24.5%) cases  were young belonging to 3rd decade then there
was a slight fall in the frequency in the next decade to 11/53(20.7%) and a sudden rise
in fifth decade to 20/53(37.7%), again there was a decrease in frequency7/53(15.1%)
as age increased to 6th decade to as low as 1/53(1.9%) in 7th decade. This pattern was
not correlating to the pattern of frequency in SS+ve cases rather correlated well to the
total number of cases.
Oral Component
54/71(76%) responded positively for the symptoms of dry mouth or
xerostomia and out of these xerostomic patients 18/54(33.3%) were diagnosed as
SS+ve cases. None of the patients who denied the presence of xerostomia symptoms
had SS. All (100%) the cases of SS showed symptoms of xerostomia. Almost 2/3rd of
the patient complained of dry mouth, this is due to referral of patients with
rheumatoid arthritis with dry mouth, despite of this selection bias only 1/3 of the cases
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went for SS positivity. This means that the predictability of xerostomia for the
possibility of patients to SS case is significant. This can be due to various causes. As
there is decrease in the salivary flow as the age increases so more patients in older age
group complained of dry mouth. Most common cause of dry mouth is side-effects of
the drugs. Patients who are suffering from connective tissue diseases are on drugs for
long time, this may also affect secretion of saliva and more patients complain of
xerostomia.
Out of 53 cases of SS-ve cases 36/53(67.9%) reported dry mouth symptoms. Rest
17/53(32.1%) denied any such symptom.  So, in SS-ve cases the number of patients
reporting dryness was almost twice than the cases which didn’t feel any oral dryness.
About 2/3rd of the cases responding positively for xerostomia in total cases were SS-
ve.
So, xerostomia is not a reliable symptom in predicting the probability of SS as only
1/3rd cases of xerostomia were diagnosed as SS.
The objective test to confirm the presence of xerostomia is done by calculating the
Unstimulated Whole Salivary Flow (UWSF). 54 cases complained of dry mouth but
only 27/54 (50 %) of cases the test was positive rest were negative on test. The test
was not positive for any of the patient without complaint of dry mouth.
In all the 18 cases of SS, dry mouth was present along with the decrease in
unstimulated whole salivary flow. None of the case showed any discrepancy between
the symptom and the objective test. This can very well be possible due to selection
bias. As serological factor remained  the major criteria; along with the minor criteria it
was used to diagnose the cases of SS. But in 90% of the cases this investigation result
was not available, so more stress was kept on these minor criteria and they showed
higher prevalence in SS+ve cases and thus showed selection bias.
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In 53 cases of SS-ve, only 9 (17%) cases showed both the subjective symptom and
objective sign of xerostomia.  27(51%) cases showed discrepancy between the
subjective symptom and the objective test. In addition, no case denying the dry mouth
symptom showed decreased whole salivary flow rate.
In contrast to SS+ve cases where not even a single case showed discrepancy between
symptom and sign, almost 2/3rd cases of SS-ve group showed this mismatch between
dry mouth symptom and objective test.
As compared to the cases affected with SS+ve , only 1/3 of the  SS-ve cases
confirmed the symptom. The sensitivity and specificity of the USWF test was 1,
0.83.  respectively.
Positive predictive and the negative predictive values 0.67, 1. respectively.
Combined effect of symptom and objective sign significantly improved the
probability of predicting the possibility of SS.
Ocular Component
31 out of total cases (43.7%) complained troublesome eyes and were considered
positive for the subjective symptom of dry eyes or Keratoconjunctivitis Sicca (KCS).
57.3% (40/71) did not complained of dry eyes. So, the ratio of positive symptoms to
negative symptoms of KCS was 0.77:1.
Less number of patients complained for dry eyes when compared to the number of
cases complaining dry mouth.
Out of 18  SS+ve cases 17(94.4%) showed KCS and only one patient didn’t complain
of dry eyes. So, the ratio of cases with and without KCS symptom was 17:1.
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14 cases of 53 (26.4%) SS-ve were symptomatic for dry eyes and 39 (73.6%) cases
were asymptomatic. So, the ratio of symptomatic to asymptomatic cases with SS-ve
diagnosis was 0.36:1.
More than 50 % of cases complaining of KCS were ultimately diagnosed as SS. This
was in contrast to the xerostomia symptom, though less number of patients were
affected by dry eyes but the patient in SS-ve group were less as compared to the
greater number of patients complaining xerostomia in SS-ve group. Positivity of KCS
was significantly higher in SS+ve cases when compared to SS-ve cases. Specificity of
this symptom was greater than the xerostomia. KCS has higher predictability than
xerostomia in predicting the possibility of SS.
33/71(46%) cases out of total sample were symptomatic for KCS. Out of these 20
(60.6%) cases showed ScT-1 test positivity but 11 (39.4%) cases couldn’t qualify this
test and failed to show decreased lacrimal flow.
Specificity and sensitivity of the Schirmer’s test  was 0.83, 0.95 respectively.
Predictive value of KCS was high as compared to the xerostomia.
Histological Features
Acinar Degeneration
34/71 case showed acinar degeneration and 37/71 cases didn’t show this
feature. So, half of the sample showed acinar degeneration. But, when we compared
the number of cases affected in individual groups, 10/18 cases showed acinar
degeneration compared to 24 /53 in SS-ve group. Though it looks as more number of
cases showed acinar degeneration in SS-ve group but due to unequal sample size the
percentage of the cases showing the degenerative feature was calculated from their
respective sample size. More than 50 % of the cases from SS +ve group were having
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degenerative process when compared to SS-ve group which shared only 30% of its
sample size.
Ductal proliferation
About 50% of the total sample showed ductal proliferation and the picture was
same as in acinar degeneration. As in the case of acinar degeneration, ductal
proliferation was seen in about 44% cases of SS+ve and affected only 33% cases of
SS-ve group. Till this, it seems that acinar degeneration and ductal proliferation go
hand in hand and affects greater cases of SS+ve group than SS-ve group.
Ductal Ectasia
Only 5 cases out of  71 case showed this feature comprising 7% of the sample
size.
Only 1/18 case showed this degenerative process comprised of 5.6% of SS+ve
sample. Rest 4 cases were from SS-ve group comprising 4.9% of the SS-ve sample.
So, actual number of cases showing ductal ectasia were not significant in both the
samples and the figures were too low to be compared of. Still, almost same share of
the cases were affected leaving us to conclude that ductal ectasia is a non specific
feature which can be present in either of the group.
So, contrary to the belief that minor salivary gland of SS+ve cases shows less
degenerative features, 20 this study showed that almost half of the sample size of
SS+ve cases had degenerative processes. This is in accordance to Chisholm62 who
said that degenerative features can be seen in SS+ve cases.
Interstitial Fibrosis
In 26/71 cases interstitial fibrosis was noted which comprised of 36.6% of
sample size. Out of this, 19 cases were from SS-ve group and 7 cases were from
SS+ve group. Though it appears that 73% of the share of interstitial fibrosis was
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shared by SS-ve group and SS+ve group constituted only 27%, but the sample size for
SS-ve group was about three times larger. Keeping that in mind the ratio of cases of
interstitial fibrosis of SS-ve group and SS+ve group was calculated that was in
accordance to the sample size. So, almost equal number of the cases showed
interstitial fibrosis.
When the number of cases were observed according to their respective sample
size it was observed that almost equal percentage of  cases showed fibrosis, thereby
making it a non specific feature when comparing SS+ve cases and SS-ve cases.
Adipose tissue
It was present only in 17/71 (24%) cases and the number of cases from both
the groups were equally affected. So, presence of adipose tissue as a histological
feature was not specific with respect to comparison of both the groups.
Vascularity
Number of vessels in minor salivary gland lobule was counted in all the cases
in high power field. Around 57.7% of the total sample showed moderate vascularity,
one quarter of the cases showed minimal vascularity and less than a quarter(16.9%)
showed high vascularity. The same pattern was seen in both the groups. In both the
groups around 50-60% cases belonged to moderate vascularity.
Around 2/3rd of SS+ve cases had moderate vascularity when compared with SS-ve
group in which slightly more than half comprised of moderate vascularity, but the
difference was not significant to arrive at any specific conclusion.
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Scattered Inflammation
Around half of the total cases showed scattered inflammatory infiltrate.
Surprisingly, around 72% of the cases of SS+ve cases showed scattered inflammation
when compared to the SS-ve group which shared only 43.4% from their respective
groups.
Focal Inflammation
Only 25% of the total sample showed foci of inflammatory cells out of which
10 cases were diagnosed as SS+ve cases and rest 8 were SS-ve cases. This was vey
surprising because focal inflammation has a good balance of specificity and
sensitivity but in this study it got reduced to slightly more than 50%. This can be due
to the unavailability of the serological investigations, which would have been there
could have transformed probable SS cases in to SS+ve cases and thus could have
increased the specificity of the focal inflammation which is considered to be
characteristic of SS+ve cases.
None of the cases showed Epimyoepithelial islands and Squamous metaplasia
which is frequently seen in the major salivary gland of SS+ve cases. Only one case of
SS+ve showed germinal center formation. One of the cases from SS-ve group showed
giant cells but when examined systemically no pathology was found except joint
pains.
Acinar degeneration was found to be increasing with age. This pattern was
followed by both the groups though the peak in SS+ve was found at an older age
when compared to the SS-ve group.
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So, it can be inferred that acinar degeneration is an aging process which can be found
in SS+ve cases affecting the older age group.
Comparison of the histological and clinical findings in cases of SS+ve cases.
18 cases constituted the SS+ve group, out of these all 18 cases complained
xerostomia with 17 cases showing positive objective result.
Acinar degeneration and ductal proliferation was found in around half of the cases
presenting with xerostomia and keratoconjunctivitis sicca. Though 72 % cases
showed scattered inflammation but other degenerative features were found in less
than 1/3rd cases.
One thing was notable that an increased number of foci was present in SS+ve
cases than SS-ve cases.
SS-ve group
36 cases complained of dry mouth out of them 20 showed acinar degeneration
and 15 cases showed ductal proliferation, 23 showed scattered inflammation.
So, a better correlation was found between clinical features in SS-ve group than
SS+ve group in relation to histological features.
Summary and Conclusion
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Summary
About 25% cases having provisional Sjogren syndrome were diagnosed as definite Sjogren’s
syndrome positive. Sjogren’s syndrome affected older age group and showed characteristic
female predilection compared to non-Sjogren’s cases. Clinical features of xerostomia and
keratoconjuctivitis sicca were seen in both Sjogren’s syndrome positive and negative cases
with more expression in Sjogren’s syndrome cases. Both showed degenerative changes on
histopathological evaluation of minor salivary glands but a better correlation was found
between clinical and histological features in non Sjogren’s cases when compared to Sjogren’s
syndrome cases
.
Conclusion:
Correlation was found between histological and clinical features in Sjogren’s syndrome, but it
was not consistently present in all the cases. Hence diagnosis of Sjogren’s syndrome should
be rendered carefully after observing clinical features and histological features.
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Annexure
Department of Oral Pathology
Tamil Nadu Government Dental College & Hospital
Chennai 600 003
PROFORMA
Name:
Age:
Gender:
Date:
Dental OP No:
Histopathology No:
GGH OP No & Date:
RCC No & Date:
Chief Complaint:
Ocular symptoms
1. Have you had daily, persistent, troublesome dry eyes for more than 3 months?
2. Do you have recurrent sensation of sand or gravel in the eyes?
3. Do you use a tear substitute more than 3 times a day?
Oral symptoms
4. Have you had a daily feeling of dry mouth for more than 3 months?
5. Have you had recurrently or persistently swollen salivary gland as an adult?
6. Do you frequently drink liquid to aid in swallowing dry foods?
Schirmer’s  test
Unstimulated whole salivary flow
History of present illness
History of past illness
ASSOCIATED CONNECTIVE TISSUE DISEASE
Rheumatoid Arthritis
Systemic Lupus Erythematosus
Polyarthritis Nodosa
Polymyositis
Scleroderma
ANY OTHER ASSOCIATED DISEASE
Kidney involvement
Lung involvement
Liver involvement
CNS disorder
Thyroid
Diabetes
Hypertension
LAB INVESTIGATIONS
Hb
ESR
TLC
DLC
RF
CRP
SSA
SSB
HISTORY OF MEDICATIONS
Any other relevant information/notes
Department of Oral Pathology
Tamil Nadu Government Dental College & Hospital
Chennai 600 003
Informed Consent Form in English
(A copy of Tamil transcript will be provided to the patient).
Study Title: The concordance of minor salivary gland histology with clinical
parameters in patients with a provisional diagnosis of Sjogren’s syndrome.
Name: O.P. No
Address: Code No
I,……………………………………………… aged……………………, exercising
my free power of choice, hereby give my consent to be included as a participant in the
study.
I agree to the following:
 I have been informed to my satisfaction about the purpose of the study and study
procedures.
 I agree to cooperate fully and also agree to report to my doctor for a regular follow
up as and when required for research.
 I have informed my doctor about all the medications that I am currently taking and
other systemic diseases that I am afflicted with.
 I herby give permission to use my medical records for research purpose. I am told
that investigating doctor and the institution will keep my identity confidential.
Name of the participant Signature/Thumb impression
Date
Name of the investigator Signature
Date
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1 12321 50 F Absent Present >5 >1.5 NC ND Absent Absent
2 12322 40 M Absent Absent >5 >1.5 NC ND Absent Absent
3 12323 30 F Absent Absent >5 >1.5 C ND Absent Absent
4 12327 45 F Absent Present >5 >1.5 NC ND Absent Present
5 12337 48 F Absent Absent >5 >1.5 NC ND Absent Present
6 12338 36 F Present Present <5 <1.5 NC ND Present Present
7 12344 25 F Present Present >5 1.5 C ND Present Present
8 12347 42 F Present Present >5 >1.5 NC ND Absent Absent
9 12350 57 F Absent Present >5 >1.5 NC ND Absent Absent
10 12352 65 F Absent Present 5 >1.5 NC Negative Absent Absent
11 12354 45 F Present Present 5 <1.5 NC ND Present Present
12 12364 47 F Present Present >5 >1.5 C ND Absent Present
13 12373 47 F Present Present <5 <1.5 NC Present Present Absent
14 12374 47 F Present Present 5 >1.5 NC Negative Absent Present
15 12375 40 F Absent Present >5 >1.5 NC ND Absent Present
16 12378 35 F Present Present <5 <1.5 C ND Present Present
17 12381 50 F Present Present >5 >1.5 NC ND Absent Present
18 12383 47 F Present Present >5 1.5 C ND Present Absent
19 12401 55 F Present Present 5 <1.5 NC ND Absent Absent
20 12403 40 F Absent Absent >5 >1.5 NC ND Absent Present
21 12408 55 F Absent Present >5 <1.5 NC ND Absent Present
22 12410 39 F Absent Present >5 <1.5 NC Negative Absent Absent
23 12413 46 M Present Present <5 <1.5 NC Negative Absent Absent
24 12415 55 F Present Present >5 >1.5 NC ND Absent Present
25 12436 52 F Present Present 5 1.5 NC Negative Present Present
26 12438 40 F Absent Present <5 >1.5 NC Negative Absent Present
27 12444 35 F Absent Absent 5 >1.5 NC ND Absent Present
28 12449 45 F Absent Present >5 >1.5 NC ND Absent Absent
29 12456 30 F Absent Present >5 >1.5 NC ND Absent Present
30 12462 32 F Present Present 5 1.5 NC Present Present Absent
31 12466 49 F Present Present >5 >1.5 C ND Absent Absent
32 12472 27 F Absent Present >5 >1.5 NC ND Absent Present
33 12479 42 F Absent Present 5 >1.5 NC ND Absent Present
34 12481 30 F Absent Present >5 <1.5 C ND Present Present
35 12483 61 F Present Present <5 1.5 NC ND Present Present
36 12493 23 F Absent Absent >5 >1.5 NC ND Absent Present
37 12502 54 F Absent Absent >5 >1.5 NC ND Absent Present
38 12504 21 F Absent Absent >5 >1.5 NC ND Absent Present
39 12507 22 F Absent Absent >5 >1.5 NC ND Absent Present
40 12519 55 F Absent Absent >5 >1.5 NC ND Absent Absent
41 12521 42 F Absent Present <5 >1.5 NC ND Absent Absent
42 12533 45 F Absent Present >5 <1.5 NC ND Absent Present
43 12538 55 F Present Present <5 <1.5 NC Present Present Present
44 12551 42 F Absent Present >5 >1.5 NC ND Absent Present
45 12553 30 F Absent Present >5 <1.5 NC ND Absent Present
46 12566 40 F Absent Absent >5 >1.5 NC ND Absent Present
47 12580 49 F Present Present >5 1.5 NC ND Absent Present
48 12582 50 F Absent Present >5 >1.5 NC ND Absent Present
49 12586 41 F Present Present <5 1.5 C ND Present Present
50 12588 29 M Absent Present >5 >1.5 NC ND Absent Absent
51 12605 55 F Present Present >5 <1.5 NC ND Absent Present
52 12608 52 F Present Present 5 <1.5 NC ND Present Present
53 12612 36 F Present Present <5 <1.5 C ND Present Present
54 12615 29 F Absent Absent >5 >1.5 NC Negative Absent Absent
55 12629 24 F Absent Present >5 >1.5 NC ND Absent Present
56 12631 32 F Present Present >5 >1.5 NC ND Absent Present
57 12632 25 F Absent Absent >5 >1.5 NC ND Absent Present
58 12643 47 F Present Present <5 >1.5 NC ND Absent Absent
59 12646 32 F Present Absent >5 >1.5 NC ND Absent Present
60 12654 36 F Absent Absent >5 >1.5 NC ND Absent Present
61 12656 46 F Absent Absent 5 >1.5 C ND Absent Present
62 12657 67 F Present Present <5 <1.5 C ND Present Present
63 12663 42 M Absent Present >5 <1.5 NC ND Absent Present
64 12666 40 F Present Present <5 >1.5 NC ND Absent Absent
65 12670 43 F Absent Present 5 >1.5 NC ND Absent Present
66 12672 28 F Absent Absent >5 >1.5 NC ND Absent Present
67 12676 28 F Absent Present >5 >1.5 NC ND Absent Absent
68 12678 47 F Present Present <5 <1.5 C ND Present Present
69 12681 55 F Present Present <5 1.5 NC ND Present Present
70 12684 60 M Absent Present >5 >1.5 NC ND Absent Present
71 12707 55 F Present Present <5 <1.5 NC ND Present Present
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1 12321 50 F NC Absent Present Present Absent Present Absent Present Absent 0.8 Absent Absent Absent Absent Absent Absent
2 12322 40 M NC Absent Present Present Present Absent Absent Absent Present 6.5 Absent Absent Absent Absent Absent Absent
3 12323 30 F C Absent Present Present Absent Present Present(2f) Present Present 6.2 Absent Absent Absent Absent Absent Absent
4 12327 45 F NC Present Present Present Absent Present Present(
<1f) Present Present 2.0 Present Absent Absent Absent Absent Absent
5 12337 48 F NC Present Absent Present Absent Present Absent Present Absent 4.8 Absent Absent Absent Absent Absent Absent
6 12338 36 F NC Present Absent Absent Absent Absent Absent Absent Absent 1.0 Absent Absent Absent Absent Absent Present
7 12344 25 F C Absent Present Present Absent Present Present(5f) Present Present 1.0 Absent Absent Absent Absent Absent Present
8 12347 42 F NC Present Absent Absent Absent Present Present(
<1f) Absent Absent 4.8 Absent Absent Absent Absent Absent Absent
9 12350 57 F NC Absent Present Present Absent Absent Absent Absent Absent 4.7 Present Absent Absent Absent Absent Absent
10 12352 65 F NC Absent Present Present Absent Present Absent Present Present 2.8 Absent Absent Absent Absent Absent Absent
11 12354 45 F NC Present Absent Absent Absent Absent Absent Absent Absent 0.5 Absent Absent Absent Absent Absent Present
12 12364 47 F C Present Absent Absent Absent Present Present(1f) Absent Absent 1.9 Absent Absent Absent Absent Absent Absent
13 12373 47 F NC Absent Present Present Absent Present Absent Present Absent 3.7 Present Absent Absent Absent Absent Present
14 12374 47 F NC Present Present Present Absent Present Present(
<1f) Present Absent 1.6 Present Absent Absent Absent Absent Absent
15 12375 40 F NC Present Present Present Absent Absent Absent Absent Absent 0.9 Present Absent Absent Absent Absent Absent
16 12378 35 F C Present Absent Absent Absent Present Present(3f) Present Absent 4.2 Absent Present Absent Absent Absent Present
17 12381 50 F NC Present Absent Present Absent Absent Absent Absent Absent 4.0 Absent Absent Absent Absent Absent Absent
18 12383 47 F C Present Absent Absent Absent Present Present(1f) Present Absent 2.4 Absent Absent Absent Absent Absent Present
19 12401 55 F NC Absent Present Present Absent Absent Absent Absent Present 5.9 Absent Absent Absent Absent Absent Absent
20 12403 40 F NC Present Present Present Absent Absent Absent Absent Absent 4.6 Absent Absent Absent Absent Absent Absent
21 12408 55 F NC Absent Present Present Absent Present Absent Present Present 4.0 Absent Absent Absent Absent Absent Absent
22 12410 39 F NC Present Absent Absent Absent Absent Absent Absent Absent 4.8 Absent Absent Absent Absent Absent Absent
23 12413 46 M NC Absent Present Absent Absent Present Absent Present Present 2.4 Absent Absent Present Absent Absent Absent
24 12415 55 F NC Present Present Present Absent Absent Absent Absent Present 5.0 Present Absent Absent Absent Absent Absent
25 12436 52 F NC Absent Present Absent Absent Present Absent Present Absent 2.0 Absent Absent Absent Absent Absent Present
26 12438 40 F NC Present Absent Absent Absent Absent Absent Absent Present 3.2 Absent Absent Absent Absent Absent Absent
27 12444 35 F NC Present Absent Absent Absent Absent Absent Absent Absent 1.0 Absent Absent Absent Absent Absent Absent
28 12449 45 F NC Absent Present Present Absent Present Absent Present Present 5.4 Present Absent Absent Absent Absent Absent
29 12456 30 F NC Present Absent Absent Absent Absent Absent Absent Absent 0.2 Absent Absent Absent Absent Absent Absent
30 12462 32 F NC Present Present Present Absent Present Present(
<1f) Absent Absent 4.2 Absent Absent Absent Absent Absent Present
31 12466 49 F C Present Present Present Absent Present Present(1f) Present Absent 5.0 Present Absent Absent Absent Absent Absent
32 12472 27 F NC Present Absent Present Absent Absent Absent Absent Absent 4.6 Absent Absent Absent Absent Absent Absent
33 12479 42 F NC Present Absent Absent Absent Absent Absent Present Absent 4.0 Absent Absent Absent Absent Absent Absent
34 12481 30 F C Present Absent Absent Absent Present Present(5f) Absent Present 4.5 Absent Absent Absent Absent Absent Present
35 12483 61 F NC Absent Present Present Absent Present Present(
<1f) Present Absent 4.3 Absent Absent Absent Absent Absent Present
36 12493 23 F NC Present Absent Absent Absent Absent Absent Absent Absent 2.3 Absent Absent Absent Absent Absent Absent
37 12502 54 F NC Absent Present Present Present Present Absent Present Present 4.0 Absent Absent Absent Absent Absent Absent
38 12504 21 F NC Present Absent Absent Absent Absent Absent Absent Absent 2.0 Absent Absent Absent Absent Absent Absent
39 12507 22 F NC Present Absent Absent Absent Absent Absent Absent Absent 1.0 Absent Absent Absent Absent Absent Absent
40 12519 55 F NC Present Absent Absent Absent Absent Absent Absent Present 4.5 Present Absent Absent Absent Absent Absent
41 12533 45 F NC Absent Present Present Present Present Absent Absent Present 1.7 Absent Absent Absent Absent Absent Absent
42 12538 55 F NC Present Present Present Absent Absent Absent Absent Absent 1.5 Present Absent Absent Absent Absent Absent
43 12551 42 F NC Present Absent Absent Absent Absent Absent Absent Absent 3.0 Absent Absent Absent Absent Absent Present
44 12553 30 F NC Present Present Present Absent Present Absent Present Absent 3.0 Present Absent Absent Absent Absent Absent
45 12566 40 F NC Present Absent Absent Absent Present Present Present Present 4.3 Absent Absent Absent Absent Absent Absent
46 12568 45 F NC Present Absent Absent Absent Absent Absent Absent Absent 3.7 Absent Absent Absent Absent Absent Absent
47 12580 49 F NC Absent Present Present Absent Present Absent Present Present 7.3 Absent Absent Absent Absent Absent Absent
48 12582 50 F NC Present Present Present Present Present Absent Present Absent 3.0 Absent Absent Absent Absent Absent Absent
49 12586 41 F C Present Present Absent Absent Present Present(5f) Present Absent 3.4 Absent Absent Absent Absent Absent Present
50 12588 29 M NC Present Absent Absent Absent Absent Absent Present Absent 4.0 Absent Absent Absent Absent Absent Absent
51 12605 55 F NC Absent Present Present Absent Present Absent Present Present 6.3 Absent Absent Absent Absent Absent Absent
52 12608 52 F NC Absent Present Present Absent Present Absent Present Absent 4.2 Present Absent Absent Absent Absent Present
53 12612 36 F C Present Absent Absent Absent Present Present(6f) Present Present 8.7 Absent Absent Absent Absent Absent Present
54 12615 29 F NC Present Absent Present Absent Absent Absent Absent Present 5.5 Absent Absent Absent Absent Absent Absent
55 12629 24 F NC Present Absent Absent Absent Present Absent Present Absent 4.3 Absent Absent Absent Absent Absent Absent
56 12631 32 F NC Present Absent Absent Absent Absent Absent Absent Absent 2.2 Absent Absent Absent Absent Absent Absent
57 12632 25 F NC Present Absent Absent Absent Absent Absent Absent Absent 5.0 Absent Absent Absent Absent Absent Absent
58 12643 47 F NC Present Present Present Absent Absent Absent Absent Absent 1.3 Absent Absent Absent Absent Absent Absent
59 12646 32 F NC Present Absent Absent Absent Present Absent Present Absent 5.2 Absent Absent Absent Absent Absent Absent
60 12654 36 F NC Present Absent Absent Absent Absent Absent Absent Absent 4.2 Absent Absent Absent Absent Absent Absent
61 12656 46 F C Present Absent Absent Absent Present Present(3f) Present Absent 3.9 Present Absent Absent Absent Absent Absent
62 12657 67 F C Absent Present Present Absent Present Present(3f) Present Present 4.4 Present Absent Absent Absent Absent Present
63 12663 42 M NC Present Absent Absent Absent Absent Absent Absent Absent 8.6 Absent Absent Absent Absent Absent Absent
64 12666 40 F NC Present Absent Absent Absent Absent Absent Absent Absent 1.3 Absent Absent Absent Absent Absent Absent
65 12670 43 F NC Present Absent Absent Absent Absent Absent Absent Absent 4.9 Absent Absent Absent Absent Absent Absent
66 12672 28 F NC Present Absent Absent Absent Present Absent Present Present 5.8 Absent Absent Absent Absent Absent Absent
67 12676 28 F NC Present Absent Absent Absent Absent Absent Absent Absent 1.5 Absent Absent Absent Absent Absent Absent
68 12678 47 F C Present Absent Absent Absent Present Present(3f) Present Present 4.5 Absent Absent Absent Absent Absent Present
69 12681 55 F NC Absent Present Present Absent Present Absent Present Present 6.8 Present Absent Absent Absent Absent Present
70 12684 60 M NC Absent Present Present Absent Present Absent Present Present 4.2 Present Absent Absent Absent Absent Absent
71 12707 55 F NC Absent Present Present Present Present Absent Present Present 3.9 Present Absent Absent Absent Absent Present

